Across TCGA pan-cancer cohorts, SFTA1P RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated SFTA1P data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher SFTA1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SFTA1P expression acts as an unfavorable survival marker, although some lineages such as LUAD and ESCA show a favorable association.
UVM, KIRP, and LUSC are the cancer types where SFTA1P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.